U R Kleeberg - JoVE Visualize

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

European Journal of Pain (London, England)|September 3, 2014

Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer painU R Kleeberg, A Davies, J Jarosz, et al.

Oncology|January 1, 1997

A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerU R Kleeberg, M Dowsett, R P Carrion, et al.

British Journal of Cancer|January 1, 1997

Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of CancerP Autier, J F Doré, O Gefeller, et al.

Cancer|September 15, 1988

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative GroupC F Verschraegen, U R Kleeberg, J Mulder, et al.

Deutsche Medizinische Wochenschrift (1946)|February 21, 1975

[Rapidly debilitating disease with generalized lymphadenopathy, skin involvement and interstitial pulmonary infiltration (report of three cases)]O Haferkamp, W Schachenmayr, U R Kleeberg, et al.

International Journal of Cancer|July 30, 1991

The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody studyS Carrel, J F Doré, D J Ruiter, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999

A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancerD A Vorobiof, U R Kleeberg, R Perez-Carrion, et al.

Onkologie|June 1, 1990

Phase II study of pirarubicin in metastatic breast cancerU R Kleeberg, L Reichel, H E Wander, et al.

Melanoma Research|April 1, 1993

Effect of Toremifene in patients with metastatic melanoma: a phase II study of the EORTC Melanoma Cooperative GroupU R Kleeberg, E Engel, E B Bröcker, et al.

European Journal of Cancer (Oxford, England : 1990)|January 30, 2004

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasisU R Kleeberg, S Suciu, E B Bröcker, et al.

Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

European Journal of Pain (London, England)|September 3, 2014

Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer painU R Kleeberg, A Davies, J Jarosz, et al.

Oncology|January 1, 1997

A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerU R Kleeberg, M Dowsett, R P Carrion, et al.

British Journal of Cancer|January 1, 1997

Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of CancerP Autier, J F Doré, O Gefeller, et al.

Cancer|September 15, 1988

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative GroupC F Verschraegen, U R Kleeberg, J Mulder, et al.

Deutsche Medizinische Wochenschrift (1946)|February 21, 1975

[Rapidly debilitating disease with generalized lymphadenopathy, skin involvement and interstitial pulmonary infiltration (report of three cases)]O Haferkamp, W Schachenmayr, U R Kleeberg, et al.

International Journal of Cancer|July 30, 1991

The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody studyS Carrel, J F Doré, D J Ruiter, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999

A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancerD A Vorobiof, U R Kleeberg, R Perez-Carrion, et al.

Onkologie|June 1, 1990

Phase II study of pirarubicin in metastatic breast cancerU R Kleeberg, L Reichel, H E Wander, et al.

Melanoma Research|April 1, 1993

Effect of Toremifene in patients with metastatic melanoma: a phase II study of the EORTC Melanoma Cooperative GroupU R Kleeberg, E Engel, E B Bröcker, et al.

European Journal of Cancer (Oxford, England : 1990)|January 30, 2004

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasisU R Kleeberg, S Suciu, E B Bröcker, et al.

Pageof 4